The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | M | Musculo-skeletal system | |
| 2 | M02 | Topical products for joint and muscular pain | |
| 3 | M02A | Topical products for joint and muscular pain | |
| 4 | M02AB | Capsaicin and similar agents |
| Code | Title | |
|---|---|---|
| M02AB01 | Capsaicin | |
| M02AB02 | Zucapsaicin |
| Active Ingredient | Description | |
|---|---|---|
| Capsaicin |
Capsaicin, or 6-nonenamide, N-[(4-hydroxy-3-methoxyphenyl) methyl]-8-methyl, (6E), is a highly selective agonist for the transient receptor potential vanilloid 1 receptor (TRPV1). The initial effect of capsaicin is the activation of TRPV1-expressing cutaneous nociceptors, which results in pungency and erythema due to the release of vasoactive neuropeptides. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| AXSAIN Cream | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| ZACIN Cream | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
